Transferrin receptor 2 is frequently and highly expressed in glioblastomas.
暂无分享,去创建一个
Silvia Deaglio | Alessia Calzolari | Ruggero De Maria | R. Pallini | L. Larocca | A. Calzolari | S. Deaglio | F. Malavasi | U. Testa | F. Pierconti | C. Raggi | R. De Maria | Ugo Testa | Roberto Pallini | Luigi Maria Larocca | Fabio Malavasi | Francesco Pierconti | V. Finisguerra | A. Boe | Lucia Ricci-Vitani | Alessandra Boe | Veronica Finisguerra | Carla Raggi | Lucia Ricci-Vitani | Alessandra Boe
[1] H. Kettenmann,et al. Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells , 2009, Journal of Molecular Medicine.
[2] Kai Simons,et al. Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.
[3] P. Ikonomi,et al. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. , 2001, Blood.
[4] G. Maira,et al. Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications , 2007, Clinical Cancer Research.
[5] A. Pellín,et al. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme. , 2005, Clinical neuropathology.
[6] C. Peschle,et al. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway , 2006, Journal of Cell Science.
[7] L. Bianchi,et al. Transferrin Receptor Induction by Hypoxia , 1999, The Journal of Biological Chemistry.
[8] L. Recht,et al. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. , 1990, Journal of neurosurgery.
[9] G. Maira,et al. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. , 2007, International journal of oncology.
[10] P. Babu,et al. Comparative status of activated ERK1/2 and PARP cleavage in human gliomas , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.
[11] M. Gobbi,et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. , 2001, Blood.
[12] W. Sly,et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Lisanti,et al. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae , 1993, The Journal of cell biology.
[14] L. Ricci-Vitiani,et al. Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme , 2008, Clinical Cancer Research.
[15] R. Pallini,et al. Glioblastoma induces vascular endothelial cells to express telomerase in vitro. , 2003, Cancer research.
[16] P. Cassoni,et al. TfR2 expression in human colon carcinomas. , 2009, Blood cells, molecules & diseases.
[17] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[18] E. Oldfield,et al. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors , 1997, Nature Medicine.
[19] Ulrich Egert,et al. FIND -- a unified framework for neural data analysis , 2009, BMC Neuroscience.
[20] M. Biffoni,et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines. , 2007, Blood cells, molecules & diseases.
[21] Rakesh K. Jain,et al. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.
[22] C. Kruchko,et al. Consensus conference on cancer registration of brain and central nervous system tumors. , 2005, Neuro-oncology.
[23] L. Ricci-Vitiani,et al. Chemotherapy resistance of glioblastoma stem cells , 2006, Cell Death and Differentiation.
[24] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[25] Harlan I. Firminger,et al. Atlas of tumor pathology , 1954 .
[26] K. Bridges,et al. Hypoxia Alters Iron-regulatory Protein-1 Binding Capacity and Modulates Cellular Iron Homeostasis in Human Hepatoma and Erythroleukemia Cells* , 1999, The Journal of Biological Chemistry.
[27] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[28] A. Stout,et al. Atlas of Tumor Pathology , 1954, American journal of clinical pathology.
[29] W. Hall,et al. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. , 1992, Journal of neurosurgery.
[30] H. Koeffler,et al. Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.
[31] D. Richardson. Iron chelators as therapeutic agents for the treatment of cancer. , 2002, Critical reviews in oncology/hematology.
[32] A. Sapino,et al. Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum. , 2002, Blood.
[33] Michael E. Berens,et al. Molecular Mechanisms of Glioma Cell Migration and Invasion , 2004, Journal of Neuro-Oncology.
[34] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[35] R. Pallini,et al. Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts , 2006, International journal of cancer.
[36] L. Ricci-Vitiani,et al. Mesenchymal differentiation of glioblastoma stem cells , 2008, Cell Death and Differentiation.
[37] B. Bacon,et al. Expression of iron-related genes in human brain and brain tumors , 2009, BMC Neuroscience.
[38] C. Peschle,et al. Signal transduction and glycophosphatidylinositol-linked proteins (lyn, lck, CD4, CD45, G proteins, and CD55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. , 1996, Blood.
[39] A. Calzolari,et al. Transferrin receptor 2 is emerging as a major player in the control of iron metabolism , 2007, Central European Journal of Biology.
[40] R K Jain,et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.
[41] Michael Weaver,et al. Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas , 2003, Journal of Neuro-Oncology.
[42] Paolo Gasparini,et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.